المؤلفون: Mehryab F; Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran., Ebrahimi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran., Baharvand H; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Department of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran., Haeri A; Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Shekari F; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

المصدر: Pharmaceutical development and technology [Pharm Dev Technol] 2024 Sep; Vol. 29 (7), pp. 727-737. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-9867 (Electronic) Linking ISSN: 10837450 NLM ISO Abbreviation: Pharm Dev Technol Subsets: MEDLINE

مواضيع طبية MeSH: Doxorubicin*/administration & dosage , Doxorubicin*/pharmacology , Spheroids, Cellular*/drug effects , Extracellular Vesicles* , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacology , Drug Liberation*, Humans ; MCF-7 Cells ; Cell Survival/drug effects ; Drug Carriers/chemistry ; Nanoparticles/chemistry

المؤلفون: Jin B; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Gu Y; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Xi S; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Liu X; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Wu X; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Wang X; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China., Li G; Department of Intensive Care Unit, Beijing You An Hospital Affiliated to the Capital Medical University, Beijing, China.

المصدر: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2024 Sep; Vol. 59 (9), pp. 1087-1092. Date of Electronic Publication: 2024 Aug 18.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0060105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1502-7708 (Electronic) Linking ISSN: 00365521 NLM ISO Abbreviation: Scand J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/mortality , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/mortality , Doxorubicin*/administration & dosage , Chemoembolization, Therapeutic*/methods , Microspheres* , Ethiodized Oil*/administration & dosage , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Treatment Outcome ; Progression-Free Survival

المؤلفون: Mc Laughlin AM; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.; Graduate Research Training Program PharMetrX, Freie Universitaet Berlin/University of Potsdam, Berlin/Potsdam, Germany., Hess D; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland., Michelet R; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany., Colombo I; Department of Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Haefliger S; Department of Medical Oncology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland., Bastian S; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland., Rabaglio M; Department of Medical Oncology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland., Schwitter M; Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland., Fischer S; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland., Eckhardt K; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland., Hayoz S; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland., Kopp C; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland., Klose M; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.; Graduate Research Training Program PharMetrX, Freie Universitaet Berlin/University of Potsdam, Berlin/Potsdam, Germany., Sessa C; Department of Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Universita della Svizzera Italiana, Lugano, Switzerland., Halbherr S; Innomedica Switzerland AG, Bern, Switzerland., Huisinga W; Institute of Mathematics, University of Potsdam, Potsdam, Germany., Joerger M; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. markus.joerger@kssg.ch., Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany. charlotte.kloft@fu-berlin.de.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Sep; Vol. 94 (3), pp. 349-360. Date of Electronic Publication: 2024 Jun 15.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Doxorubicin*/analogs & derivatives , Doxorubicin*/pharmacokinetics , Doxorubicin*/administration & dosage , Polyethylene Glycols*/pharmacokinetics , Polyethylene Glycols*/administration & dosage , Neoplasms*/drug therapy , Antibiotics, Antineoplastic*/pharmacokinetics , Antibiotics, Antineoplastic*/administration & dosage, Humans ; Female ; Middle Aged ; Male ; Aged ; Adult ; Models, Biological ; Half-Life ; Area Under Curve ; Dose-Response Relationship, Drug

المؤلفون: Sattler S; National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK. susanne.sattler@medunigraz.at.; Department of Pharmacology, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria. susanne.sattler@medunigraz.at.; Department of Cardiology, LKH Univ. Klinikum Graz, Medical University of Graz, Graz, Austria. susanne.sattler@medunigraz.at., Ljubojevic-Holzer S; National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK.; Department of Pharmacology, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.; Department of Cardiology, LKH Univ. Klinikum Graz, Medical University of Graz, Graz, Austria.

المصدر: Nature cardiovascular research [Nat Cardiovasc Res] 2024 Aug; Vol. 3 (8), pp. 890-892.

نوع المنشور: News

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 9918284280206676 Publication Model: Print Cited Medium: Internet ISSN: 2731-0590 (Electronic) Linking ISSN: 27310590 NLM ISO Abbreviation: Nat Cardiovasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibiotics, Antineoplastic*/adverse effects , Antibiotics, Antineoplastic*/therapeutic use , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/drug effects , Doxorubicin*/adverse effects , Doxorubicin*/therapeutic use , Heart Failure*/immunology, Animals ; Humans ; Cardiotoxicity/etiology ; Risk Factors

المؤلفون: Wang F; College of Engineering and Applied Sciences, Nanjing University, Nanjing, Jiangsu 210023, China., Qin S; College of Engineering and Applied Sciences, Nanjing University, Nanjing, Jiangsu 210023, China., Zhang J; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210093, China., Huang M; College of Engineering and Applied Sciences, Nanjing University, Nanjing, Jiangsu 210023, China., Liu Q; The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210093, China. Electronic address: liuqin@nju.edu.cn., Xu P; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210093, China. Electronic address: xu_peipei0618@163.com., Hu Y; College of Engineering and Applied Sciences, Nanjing University, Nanjing, Jiangsu 210023, China; Nanjing University (Suzhou) High-tech Institute, Renai Road 150, Suzhou Industrial Park, Suzhou 215123, China. Electronic address: hvyong@nju.edu.cn.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Jul 20; Vol. 660, pp. 124349. Date of Electronic Publication: 2024 Jun 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Doxorubicin*/administration & dosage , Doxorubicin*/pharmacology , Fas Ligand Protein*/metabolism , Extracellular Vesicles* , fas Receptor*/metabolism , Nitroprusside*/administration & dosage , Apoptosis*/drug effects , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacology, Animals ; Cell Line, Tumor ; Mice ; Nitric Oxide/metabolism ; Immunotherapy/methods ; Mice, Inbred C57BL ; Female ; Neoplasms/drug therapy ; Neoplasms/therapy ; Neoplasms/immunology ; Humans ; Signal Transduction/drug effects ; Mice, Inbred BALB C ; Drug Delivery Systems/methods

المؤلفون: Musella F; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Cardiology Department, Santa Maria delle Grazie Hospital, Naples, Italy. Electronic address: Francesca.musella@ki.se., Librera M; Cardiac Multi-Imaging Unit, Mediterranea Cardiocentro, Via Orazio 2, 80122 Naples, Italy., Sibilio G; Cardiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Boccalatte M; Cardiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Tagliamonte G; Cardiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Cavaglià E; Radiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Ferrara I; Radiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Puglia M; Radiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Dell'Aversana S; Radiology Department, Santa Maria delle Grazie Hospital, Naples, Italy., Ducci CB; Royal Brompton and Harefield Hospitals and Guys' and St Thomas NHS Trust, London, UK., Dellegrottaglie S; Advanced Cardiovascular Imaging Unit, Clinica Villa dei Fiori Acerra, Naples, Italy., Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Heart and Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden., Scatteia A; Advanced Cardiovascular Imaging Unit, Clinica Villa dei Fiori Acerra, Naples, Italy.

المصدر: Current problems in cardiology [Curr Probl Cardiol] 2024 Jul; Vol. 49 (7), pp. 102609. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7701802 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6280 (Electronic) Linking ISSN: 01462806 NLM ISO Abbreviation: Curr Probl Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Anthracyclines*/adverse effects , Anthracyclines*/therapeutic use , Stroke Volume*/drug effects , Stroke Volume*/physiology , Cardiotoxicity*/etiology , Cardiotoxicity*/diagnosis , Ventricular Function, Left*/drug effects , Ventricular Function, Left*/physiology , Antibiotics, Antineoplastic*/adverse effects , Antibiotics, Antineoplastic*/therapeutic use, Humans ; Neoplasms/drug therapy ; Magnetic Resonance Imaging, Cine/methods ; Adult

المؤلفون: Wang S; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Institute of Immunology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou 310006, China., Qiao C; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Kong X; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Yang J; Department of Critical Care Medicine of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Guo F; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai 200433, China., Chen J; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Wang W; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Zhang B; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., Xiu H; Department of Critical Care Medicine of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China., He Y; Department of Emergency, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: hyzxy1995@126.com., Wang J; Institute of Immunology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou 310006, China. Electronic address: jlwang@zju.edu.cn., Feng H; Ecological-Environment & Health College, Zhejiang A & F University, Hangzhou, Zhejiang 311300, China. Electronic address: fenghuajun@zafu.edu.cn., Cai Z; Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: caizj@zju.edu.cn.

المصدر: Pharmacological research [Pharmacol Res] 2024 Jul; Vol. 205, pp. 107244. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

مواضيع طبية MeSH: Doxorubicin*/pharmacology , Doxorubicin*/administration & dosage , Intercellular Adhesion Molecule-1*/metabolism , Extracellular Vesicles*/metabolism , Extracellular Vesicles*/drug effects , Antibiotics, Antineoplastic*/pharmacology , Antibiotics, Antineoplastic*/administration & dosage, Animals ; Humans ; Cell Line, Tumor ; Mice, Inbred BALB C ; Mice ; Female ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Cell Adhesion/drug effects ; Drug Delivery Systems ; Mice, Nude ; Tumor Necrosis Factor-alpha/metabolism

المؤلفون: Lee JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee CU; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Chung JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Song W; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kang M; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jeon HG; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sung HH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

المصدر: Cancer research and treatment [Cancer Res Treat] 2024 Jul; Vol. 56 (3), pp. 877-884. Date of Electronic Publication: 2024 Jan 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Epirubicin*/administration & dosage , Epirubicin*/therapeutic use , Nephroureterectomy*/methods , Urinary Bladder Neoplasms*/surgery , Urinary Bladder Neoplasms*/pathology , Neoplasm Recurrence, Local*/prevention & control , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use, Humans ; Administration, Intravesical ; Female ; Male ; Aged ; Retrospective Studies ; Middle Aged ; Carcinoma, Transitional Cell/surgery ; Carcinoma, Transitional Cell/pathology ; Aged, 80 and over ; Ureteral Neoplasms/surgery ; Ureteral Neoplasms/pathology ; Ureteral Neoplasms/drug therapy

المؤلفون: Makipour A; Department of Basic Sciences, Division of Histology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Electronic address: azam.makipour@gmail.com., Hosseinifar S; Department of Basic Sciences, Division of Histology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Electronic address: sh.hosseinifar@scu.ac.ir., Khazaeel K; Department of Basic Sciences, Division of Anatomy and Embryology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran; Stem Cells and Transgenic Technology Research Center (STTRC), Shahid Chamran University of Ahvaz, Ahvaz, Iran. Electronic address: k.khazaeil@scu.ac.ir., Tabandeh MR; Department of Basic Sciences, Division of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran; Stem Cells and Transgenic Technology Research Center (STTRC), Shahid Chamran University of Ahvaz, Ahvaz, Iran. Electronic address: m.tabandeh@scu.ac.ir., Jamshidian J; Department of Basic Sciences, Division of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Electronic address: j.jamshidian@scu.ac.ir.

المصدر: Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 2024 Sep; Vol. 128, pp. 108653. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon In Cooperation With The Reproductive Toxicology Center Country of Publication: United States NLM ID: 8803591 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-1708 (Electronic) Linking ISSN: 08906238 NLM ISO Abbreviation: Reprod Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Testis*/drug effects , Testis*/pathology , Testis*/metabolism , Chlorella vulgaris* , Oxidative Stress*/drug effects , Spermatozoa*/drug effects , Doxorubicin*/toxicity , Rats, Wistar* , Apoptosis*/drug effects , Testosterone*/blood , Antibiotics, Antineoplastic*/toxicity, Animals ; Male ; Plant Extracts/pharmacology ; Androgens ; Antioxidants/pharmacology ; Protective Agents/pharmacology ; Rats

المؤلفون: Matusik K; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland., Kamińska K; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. kkaminska@wum.edu.pl., Sobiborowicz-Sadowska A; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland., Borzuta H; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland., Buczma K; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland., Cudnoch-Jędrzejewska A; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.

المصدر: Heart failure reviews [Heart Fail Rev] 2024 Sep; Vol. 29 (5), pp. 969-988. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9612481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7322 (Electronic) Linking ISSN: 13824147 NLM ISO Abbreviation: Heart Fail Rev Subsets: MEDLINE

مواضيع طبية MeSH: Doxorubicin*/adverse effects , Cardiotoxicity*/etiology , Antibiotics, Antineoplastic*/adverse effects , Apelin*/metabolism, Humans ; Animals ; Oxidative Stress/drug effects ; Neoplasms/drug therapy ; Apelin Receptors/metabolism